Detalhe da pesquisa
1.
Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.
Pituitary
; 21(4): 355-361, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564694
2.
The effects of cabergoline in the presurgical and recurrence periods of Cushing's disease patients.
Minerva Endocrinol (Torino)
; 2021 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881856
3.
gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
Cancers (Basel)
; 13(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638340
4.
Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor Ligands.
J Clin Endocrinol Metab
; 106(7): 2047-2056, 2021 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686418
5.
Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment.
Pituitary
; 12(4): 297-303, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19330452
6.
Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma: A Single-Center, Open-Label, 2-Year Randomized Clinical Trial.
Am J Clin Oncol
; 42(2): 221-227, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30540568
7.
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
Arch Endocrinol Metab
; 62(2): 236-263, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768629
8.
A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
Arch Endocrinol Metab
; 60(4): 374-90, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533614
9.
[Dopamine-agonist resistant prolactinomas: diagnosis and management]. / Prolactinomas resistentes a agonistas dopaminérgicos: diagnóstico e manejo.
Arq Bras Endocrinol Metabol
; 49(5): 641-50, 2005 Oct.
Artigo
em Português
| MEDLINE | ID: mdl-16444347
10.
Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal.
J Clin Endocrinol Metab
; 87(8): 3578-82, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12161478
11.
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
Arch. endocrinol. metab. (Online)
; 62(2): 236-263, Mar.-Apr. 2018. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-887642
12.
A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
Arch. endocrinol. metab. (Online)
; 60(4): 374-390, Aug. 2016. tab, graf
Artigo
em Inglês
| LILACS | ID: lil-792938
13.
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil]. / Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o diagnóstico e tratamento da acromegalia no Brasil.
Arq Bras Endocrinol Metabol
; 55(2): 91-105, 2011 Mar.
Artigo
em Português
| MEDLINE | ID: mdl-21584426
14.
Treatment of acromegaly: is there still a place for radiotherapy?
Pituitary
; 10(1): 53-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17318438
15.
Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
Clin Endocrinol (Oxf)
; 67(2): 310-5, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17555503
16.
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil]. / Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o diagnóstico e tratamento da acromegalia no Brasil.
Arq Bras Endocrinol Metabol
; 55(9): 725-6, 2011 Dec.
Artigo
em Português
| MEDLINE | ID: mdl-22231978
17.
Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o diagnóstico e tratamento da acromegalia no Brasil / Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil
Arq. bras. endocrinol. metab
; 55(2): 91-105, mar. 2011. ilus, tab
Artigo
em Português
| LILACS | ID: lil-586492
18.
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
Clin Endocrinol (Oxf)
; 63(2): 168-75, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16060910
19.
Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o Diagnóstico e Tratamento da Acromegalia no Brasil / Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for Diagnosis and Treatment of Acromegaly in Brazil
Arq. bras. endocrinol. metab
; 55(9): 725-726, dez. 2011.
Artigo
em Português
| LILACS | ID: lil-610483
20.
Prolactinomas resistentes a agonistas dopaminérgicos: diagnóstico e manejo / Dopamine-agonists-resistant prolactinomas: diagnosis and management
Arq. bras. endocrinol. metab
; 49(5): 641-650, out. 2005. ilus
Artigo
em Português
| LILACS | ID: lil-419966